# Effect of Plavix on NO (Nitrogen Monoxide) Production of the Endothelial Function

> **NCT00648453** · PHASE4 · COMPLETED · sponsor: **Sanofi** · enrollment: 39 (actual)

## Conditions studied

- Peripheral Arterial Disease

## Interventions

- **DRUG:** Clopidogrel (Plavix)

## Key facts

- **NCT ID:** NCT00648453
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-12
- **Primary completion:** —
- **Final completion:** 2004-04
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2008-04-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00648453

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00648453, "Effect of Plavix on NO (Nitrogen Monoxide) Production of the Endothelial Function". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00648453. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*